Mitochondria-targeted nanotechnology in cardiovascular diseases: a review of recent advances
{{output}}
Cardiovascular diseases (CVDs) remain the leading cause of global mortality, with mitochondrial dysfunction serving as a central pathological hub in conditions such as atherosclerosis, myocardial ischemia-reperfusion injury and heart failure. Current mitochond... ...
